Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Levetiracetam NDC 25021-780 by Sagent Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

lev00 0016 01

lev00 0016 01

lev00 0016 02

lev00 0016 02

This appears to be a table showing the percentage of a certain variable across different treatment groups. However, without more context or information on what the variable represents, it is unclear what the practical implications of this data would be.*

lev00 0016 03

lev00 0016 03

This appears to be a table with percentages and medication names. The percentages may represent effectiveness or dosages. However, without further context or headers, it is difficult to provide a complete and accurate description.*

lev00 0016 04

lev00 0016 04

This appears to be a table comparing the effectiveness of Placebo and Levetiracetam at a daily dose of 3,000mg for an unknown condition. The first two lines list percentages, but without context it is unclear what they represent. The table includes two groups - Placebo with 104 participants and Levetiracetam with 180 participants.*

lev00 0016 05

lev00 0016 05

This could be a graph or chart related to clinical trial or medical study, where the percentages denote some kind of statistical measure or result. However, without any context or labels, it is impossible to ascertain what the percentages are actually representing.*

lev00 0016 06

lev00 0016 06

The text shows the percentages of two treatment groups, Placebo and Levetiracetam, for an unknown study with sample sizes of 51 and 58, respectively. Not available information on the context or purpose of the study.*

lev00 0016 07

lev00 0016 07

This appears to be a table containing percentages of patients for two groups, one being a placebo group with 84 patients and the other receiving Levetiracetam, a medication commonly used to treat seizures. However, the text does not provide enough context to understand the purpose or results of this table.*

lev00 0016 08

lev00 0016 08

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.